Quarterly report pursuant to Section 13 or 15(d)

Segment and Geographic Information

v3.8.0.1
Segment and Geographic Information
9 Months Ended
Sep. 30, 2017
Segment Reporting [Abstract]  
Segment and Geographic Information

12. Segment and Geographic Information

The Company has one operating and reportable segment, R&D of plant gene editing. The Company derives substantially all of its revenue from R&D contracts related to plant gene editing located in the US.